Cannabismarketcap

Trulieve Cannabis Stock Forecast & Price Prediction 2026-2027

Algorithmic price targets and analysis for TRLV based on fundamentals, valuation multiples, and historical data.

$10.12+1.45%
Neutral

Price Target Summary

Bear Case
$8.09
-20.0% from current
Base Case
$14.21
+40.5% from current
Bull Case
$25.58
+152.9% from current

Technical Outlook

52-Week Range Analysis

$7.82$12.93
Current: $10.12
Support Level
$8.33
Resistance Level
$12.42
From 52W High
-21.8%
From 52W Low
+29.3%

Fundamental Analysis

Revenue Growth Projection

Year 1 Projected
$1.09B
Year 2 Projected
$1.06B
Year 3 Projected
$1.04B

Based on -3.9% YoY growth, tapered 20% per year in outer projections.

Valuation vs Peers

Current P/S
1.70x
Sector Median P/S
2.5x
Assessment
Undervalued vs sector

Cash Position

Cash on Hand
$325.4M
Total Debt
$195.8M

Key Metrics

Current Price$10.12
Market Cap$1.94B
P/S Ratio1.70x
Revenue (TTM)$1.14B
Revenue Growth (YoY)-3.9%
Gross Margin59.5%
Cash on Hand$325.4M
Total Debt$195.8M
52W High$12.93
52W Low$7.82

Signal Breakdown

Overall Signal: Neutral
  • Negative or flat revenue growth
  • Healthy gross margins above 40%
  • Cash exceeds total debt
  • P/S ratio below sector median suggests upside

Risk Factors

  • Revenue is declining year-over-year (-3.9%), which may pressure valuation multiples.

Analyst Summary

Trulieve Cannabis (TRLV) is a multi-state cannabis operator (MSO) with contracting revenue and a market capitalization of $1.94B. Based on trailing revenue of $1.14B and a P/S ratio of 1.70x, the stock appears undervalued relative to the sector median of 2.5x. Our algorithmic base-case price target of $14.21 implies upside of 40.5% from current levels. The overall signal is neutral, with a mixed fundamental picture. Investors should weigh the 1 identified risk factor before making any investment decision.

Frequently Asked Questions

What is the price target for TRLV?+
Our algorithmic base-case price target for Trulieve Cannabis (TRLV) is $14.21, with a bear case of $8.09 and a bull case of $25.58. These targets are derived from sector-average and premium P/S multiples applied to projected revenue.
Is TRLV a buy right now?+
Based on our algorithmic analysis, TRLV currently carries a neutral signal. Negative or flat revenue growth. Healthy gross margins above 40%. This is not a buy or sell recommendation — always do your own due diligence.
What is the revenue forecast for Trulieve Cannabis?+
Based on the current year-over-year growth rate of -3.9%, we project TRLV revenue at $1.09B in Year 1, $1.06B in Year 2, and $1.04B in Year 3. Growth rates are tapered in outer years.
What are the risks of investing in TRLV?+
Revenue is declining year-over-year (-3.9%), which may pressure valuation multiples.
How does TRLV valuation compare to the cannabis sector?+
TRLV has a trailing P/S ratio of 1.70x compared to the cannabis sector median of 2.5x. The stock undervalued vs sector.

Important Disclaimer

This is not financial advice. Forecasts are algorithmic projections based on historical data and should not be used as the sole basis for investment decisions. Past performance does not guarantee future results. Cannabis stocks carry significant risk including regulatory, market, and operational risks. Always consult with a qualified financial advisor before making investment decisions. Cannabismarketcap does not recommend buying, selling, or holding any security.

← Back to TRLV OverviewAll Cannabis Stocks